Michel Nussenzweig, MD, PhD, an LRI Scientific Board member and the head of Rockefeller University’s Laboratory of Molecular Immunology, has been elected to the National Academy of Sciences, the nation's preeminent organization of scientists advising Congress and the U.S. government on science and technology.
“We congratulate Dr. Nussenzweig—a key advisor and invaluable guide in our hunt for solutions to the complex and dangerous autoimmune disease of lupus—on receiving one of the highest honors in science,” said LRI President Margaret Dowd.
Members of the academy are elected in recognition of their distinguished and continuing achievements in original research. “Michel has made seminal contributions to our understanding of the molecular mechanisms underlying adaptive and innate immunity,” explained Rockefeller University President Marc Tessler-Lavigne in a statement.
Drawing on a combination of techniques from biochemistry, molecular biology, gene targeting and more, Dr. Nussenzweig has explored the working of the immune system at an atomic level and also has made critical advances in promising new treatments of autoimmune diseases. These are just a few of his contributions.
The LRI’s Scientific Advisory Board Chairman, NIH-NIAID’s William E. Paul, is also one of the over 2,110 members (plus 418 foreign associates) of the preeminent academy.